The<unk> , also known as<unk> , was a randomized, double-blind, placebo-controlled clinical trial, published in 1995. It compared 40mg of the lipid-lowering drug pravastatin to placebo in 6, 595 men who had a mean cholesterol of 7 mmol/L but no previous history of a heart attack. The study concluded that statin treatment for primary<unk>  reduced<unk>  heart disease (CHD) events by 31% after nearly five years of treatment.
West of Scotland Coronary Prevention Study
Cohorts for Heart and Aging Research in Genomic Epidemiology
European Prospective Investigation into Cancer and Nutrition
HDL-Atherosclerosis Treatment Study
British birth cohort studies
RECOVERY Trial
Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
MOMS Trial